Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AArcturus Therapeutics Holdings Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Arcturus Therapeutics Holdings Inc.

$14.38Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $2.96M. Net result −$23.79M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $2.96M. Running result $2.96M. Collaboration Revenue: $880K. Grant: $2.08M.
  • Cost of revenue: $0. Running result $2.96M.
  • Gross profit: $2.96M. Running result $2.96M.
  • Research and development, net: −$17.52M. Running result −$14.56M.
  • General and administrative: −$10.99M. Running result −$25.55M.
  • Operating income: −$25.55M. Running result −$25.55M.
  • Other income: $1.76M. Running result −$23.79M.
  • Pre-tax loss: −$23.79M. Running result −$23.79M.
  • Income tax benefit: $0. Running result −$23.79M.
  • Net loss: −$23.79M. Running result −$23.79M.